Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$473.42 - $539.26 $202,623 - $230,803
-428 Reduced 26.97%
1,159 $622,000
Q1 2023

May 08, 2023

BUY
$335.35 - $386.06 $532,200 - $612,677
1,587 New
1,587 $565,000
Q1 2022

May 12, 2022

SELL
$244.61 - $310.48 $604,675 - $767,506
-2,472 Closed
0 $0
Q4 2021

Jan 14, 2022

SELL
$198.21 - $248.9 $11,297 - $14,187
-57 Reduced 2.25%
2,472 $615,000
Q1 2021

May 11, 2021

BUY
$169.52 - $196.53 $104,085 - $120,669
614 Added 32.06%
2,529 $493,000
Q4 2020

Feb 08, 2021

SELL
$143.79 - $183.66 $2,588 - $3,305
-18 Reduced 0.93%
1,915 $333,000
Q2 2020

Aug 07, 2020

SELL
$125.49 - $164.68 $169,787 - $222,812
-1,353 Reduced 41.17%
1,933 $290,000
Q1 2020

May 07, 2020

SELL
$115.75 - $170.96 $788,257 - $1.16 Million
-6,810 Reduced 67.45%
3,286 $444,000
Q4 2019

Feb 10, 2020

BUY
$130.23 - $153.27 $273,483 - $321,867
2,100 Added 26.26%
10,096 $1.39 Million
Q2 2019

Aug 14, 2019

SELL
$112.47 - $134.93 $11,247 - $13,493
-100 Reduced 1.24%
7,996 $1.08 Million
Q1 2019

May 09, 2019

SELL
$111.86 - $136.3 $33,558 - $40,890
-300 Reduced 3.57%
8,096 $943,000
Q4 2018

Feb 11, 2019

SELL
$108.23 - $136.84 $595,265 - $752,620
-5,500 Reduced 39.58%
8,396 $924,000
Q3 2018

Oct 18, 2018

SELL
$123.14 - $138.52 $198,009 - $222,740
-1,608 Reduced 10.37%
13,896 $1.84 Million
Q2 2018

Aug 15, 2018

SELL
$133.4 - $158.13 $133,400 - $158,130
-1,000 Reduced 6.06%
15,504 $2.07 Million
Q1 2018

Apr 26, 2018

BUY
$138.75 - $176.72 $222,000 - $282,752
1,600 Added 10.74%
16,504 $2.33 Million
Q4 2017

Jan 19, 2018

BUY
$135.02 - $162.6 $27,004 - $32,520
200 Added 1.36%
14,904 $2.33 Million
Q3 2017

Nov 06, 2017

BUY
$146.0 - $161.87 $2.15 Million - $2.38 Million
14,704
14,704 $1.99 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $90B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Lingohr & Partner Asset Management Gmb H Portfolio

Follow Lingohr & Partner Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.